Ignite Creation Date:
2024-05-05 @ 10:53 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01206088
Status:
COMPLETED
Last Update Posted:
2017-02-28
First Post:
2010-09-20
Brief Title:
Tasigna in Glivec-resistant or Intolerant Patients in CML
Sponsor:
Organization:
Novartis